Zhangzhou Pientzehuang Pharmaceutical., Statistics
Total Valuation
Zhangzhou Pientzehuang Pharmaceutical., has a market cap or net worth of CNY 122.15 billion. The enterprise value is 114.74 billion.
Market Cap | 122.15B |
Enterprise Value | 114.74B |
Important Dates
The next estimated earnings date is Wednesday, October 16, 2024.
Earnings Date | Oct 16, 2024 |
Ex-Dividend Date | Jun 7, 2024 |
Share Statistics
Zhangzhou Pientzehuang Pharmaceutical., has 603.32 million shares outstanding. The number of shares has decreased by -0.15% in one year.
Shares Outstanding | 603.32M |
Shares Change (YoY) | -0.15% |
Shares Change (QoQ) | +0.83% |
Owned by Insiders (%) | 4.49% |
Owned by Institutions (%) | 8.54% |
Float | 230.70M |
Valuation Ratios
The trailing PE ratio is 40.98 and the forward PE ratio is 37.99. Zhangzhou Pientzehuang Pharmaceutical.,'s PEG ratio is 1.86.
PE Ratio | 40.98 |
Forward PE | 37.99 |
PS Ratio | 11.44 |
PB Ratio | 8.94 |
P/FCF Ratio | 109.50 |
PEG Ratio | 1.86 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.46, with an EV/FCF ratio of 102.85.
EV / Earnings | 38.53 |
EV / Sales | 10.76 |
EV / EBITDA | 32.46 |
EV / EBIT | 33.44 |
EV / FCF | 102.85 |
Financial Position
The company has a current ratio of 5.99, with a Debt / Equity ratio of 8.47.
Current Ratio | 5.99 |
Quick Ratio | 4.04 |
Debt / Equity | 8.47 |
Debt / EBITDA | 0.34 |
Debt / FCF | 1.08 |
Interest Coverage | 90.27 |
Financial Efficiency
Return on equity (ROE) is 22.39% and return on invested capital (ROIC) is 14.71%.
Return on Equity (ROE) | 22.39% |
Return on Assets (ROA) | 13.01% |
Return on Capital (ROIC) | 14.71% |
Revenue Per Employee | 3.82M |
Profits Per Employee | 1.07M |
Employee Count | 2,789 |
Asset Turnover | 0.65 |
Inventory Turnover | 1.64 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.61% in the last 52 weeks. The beta is 0.72, so Zhangzhou Pientzehuang Pharmaceutical.,'s price volatility has been lower than the market average.
Beta (5Y) | 0.72 |
52-Week Price Change | -26.61% |
50-Day Moving Average | 208.84 |
200-Day Moving Average | 224.44 |
Relative Strength Index (RSI) | 42.84 |
Average Volume (20 Days) | 1,126,496 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zhangzhou Pientzehuang Pharmaceutical., had revenue of CNY 10.66 billion and earned 2.98 billion in profits. Earnings per share was 4.94.
Revenue | 10.66B |
Gross Profit | 4.86B |
Operating Income | 3.43B |
Pretax Income | 3.57B |
Net Income | 2.98B |
EBITDA | 3.50B |
EBIT | 3.43B |
Earnings Per Share (EPS) | 4.94 |
Balance Sheet
The company has 9.20 billion in cash and 1.21 billion in debt, giving a net cash position of 7.99 billion or 13.25 per share.
Cash & Cash Equivalents | 9.20B |
Total Debt | 1.21B |
Net Cash | 7.99B |
Net Cash Per Share | 13.25 |
Equity (Book Value) | 14.24B |
Book Value Per Share | 22.66 |
Working Capital | 12.60B |
Cash Flow
In the last 12 months, operating cash flow was 1.22 billion and capital expenditures -103.93 million, giving a free cash flow of 1.12 billion.
Operating Cash Flow | 1.22B |
Capital Expenditures | -103.93M |
Free Cash Flow | 1.12B |
FCF Per Share | 1.85 |
Margins
Gross margin is 45.53%, with operating and profit margins of 32.17% and 27.93%.
Gross Margin | 45.53% |
Operating Margin | 32.17% |
Pretax Margin | 33.48% |
Profit Margin | 27.93% |
EBITDA Margin | 32.81% |
EBIT Margin | 32.17% |
FCF Margin | 10.46% |
Dividends & Yields
This stock pays an annual dividend of 2.32, which amounts to a dividend yield of 1.15%.
Dividend Per Share | 2.32 |
Dividend Yield | 1.15% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 6 |
Payout Ratio | 73.47% |
Buyback Yield | 0.15% |
Shareholder Yield | 1.29% |
Earnings Yield | 2.44% |
FCF Yield | 0.91% |
Stock Splits
The last stock split was on May 24, 2016. It was a forward split with a ratio of 1.5.
Last Split Date | May 24, 2016 |
Split Type | Forward |
Split Ratio | 1.5 |